The landscape of dementia prognosis has evolved radically with the advent of innovative biomarkers, including amyloid PET scans, tau imaging, and blood-based assessments which will detect Alzheimer's pathology several years just before signs and symptoms arise. Although these technological improvements signify remarkable development in comprehension neurodegenerative ailments, they ha... https://rogera975wfo4.theobloggers.com/profile